查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1466199

心房颤动手术市场：按产品、适应症和最终用户 - 2024-2030 年全球预测

Atrial Fibrillation Surgery Market by Product (Cardiac Cryoablation Catheters, Cardiac Mapping System), Indication (Atrial Fibrillation (AFib), Atrial Flutter, Supraventricular Tachycardia (SVT)), End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

心房颤动手术市场规模预估2023年为26.7亿美元，2024年达29亿美元，预估2030年将达48.8亿美元，复合年增长率为9.00%。

心房颤动手术是治疗心房颤动 (AFib) 的医疗程序。心房颤动通常是一种不规则且快速的心率，可导致血流不良、中风和其他心血管併发症。心房颤动手术的主要类型包括心导管电气烧灼术、手术消融和左心耳封堵术（LAAC）。多年来，糖尿病和高血压等慢性疾病的盛行率显着增加，这些慢性疾病是心房颤动发生的主要危险因素，导致对有效心房颤动治疗方案的需求急剧增加。心导管电气烧灼术等微创技术的创新显着改善了患者的治疗效果，同时缩短了恢復时间。然而，与心房颤动手术产品相关的产品召回、手术报销的限制以及执行手术的外科医生的有限性也对市场产生了影响。市场参与者正在开发价格实惠的设备和技术，以改善不同社会经济背景的患者获得救生治疗的机会。人工智慧、机器人和生物电子医学等领域的持续研究有望开发出创新的心房颤动手术解决方案，进一步改善患者的治疗效果并最大限度地减少併发症。

主要市场统计
基准年[2023] 26.7亿美元
预测年份 [2024] 29亿美元
预测年份 [2030] 48.8亿美元
复合年增长率（%） 9.00%

使用产品导管进行微创手术的需求正在增加。

心导管电气烧灼术产品是微创手术，用于透过隔离肺静脉并在心臟组织中产生损伤来破坏异常电信号来治疗心房颤动 (AF)。这些产品为不适合进行心臟直视手术或希望更快恢復时间的患者提供了一种侵入性较小的选择。外科消融产品包括多种技术，例如迷宫（剪切和粘贴）、射频 (RF) 消融和冷冻消融，在心臟直视手术期间或采用包括胸腔镜手术在内的微创方法进行。这些产品可解决更复杂的心律不整问题，而仅使用基于导管的技术无法有效治疗这些心律不整。儘管基于导管的手术是首选，因为它们具有微创性并且可以快速恢復，但手术选择可以为仅通过基于导管的手术无法充分解决的复杂心律不整提供更全面的治疗。

迷宫手术作为适应性心房颤动的首选治疗方法的出现

心律不整是由心臟异常电活动引起的心律不整。心房颤动是最常见的心律不整，影响着全世界数百万人。迷宫手术、肺静脉隔离（PVI）和左心耳阻塞术（LAAC）是治疗心房颤动的常见外科手术。心房扑动是一种较不常见的心律不整，其特征是源自心房的快速、规则的电讯号。如果心导管电气烧灼术是首选治疗方法，但由于患者因素导致消融不成功或不适合，则可能需要进行心房颤动手术。室上性心搏过速是发生在心室上方的快速心率。心导管电气烧灼术是SVT的主要治疗方法，当有多个致心律不整病灶或消融失败时可考虑心房颤动手术。

最终用户：加快在循环系统医学和多中心环境中进行心房颤动手术的速度

在心房颤动手术中，循环系统和多学科实践对于心房颤动手术介入都有不同的要求和偏好。循环系统科诊所优先考虑专门为心房颤动治疗设计的设备，而多学科诊所则需要跨学科和患者群体的多功能性。循环系统专门诊断和治疗包括心房颤动在内的心臟疾病，需要先进的设备和技术，以及新型冲洗式射频消融导管。心导管电气烧灼术等微创方法因其成功率高、减少患者不适且恢復时间更快而受到循环系统的青睐。多专业实践透过将各种医学专业集中在一个屋檐下，提供了一种全面的患者照护方法。在这些环境中，心电图机、超音波心动图系统和心臟监测设备等诊断设备和工具用于准确诊断和治疗心房颤动。

区域洞察

在成熟的医疗基础设施和执行外科手术的有利报销政策的推动下，北美市场格局正在不断发展。该地区拥有多种获得美国食品药物管理局（FDA）和加拿大卫生署核准的创新药物和医疗设备，改善了开发环境。在亚太地区，随着越来越多的心血管疾病患者接受手术，心房颤动手术在印度、日本和中国等国家迅速增加。亚洲医疗旅游业的显着增长正在加速该地区进行的手术数量，并扩大了对先进手术工具和设备的需求。亚洲的心房颤动手术产量正在成长，特别是在中国和日本。这是因为领先的医疗设备製造商专注于开发具有成本效益的解决方案，以满足对负担得起的医疗服务不断增长的需求。欧洲是心房颤动的另一个重要市场，许多欧洲公司专注于开发用于心房颤动手术的创新心臟设备。各大公司正大力投资研发活动，旨在改善手术技术，以有效治疗心房颤动患者。

FPNV定位矩阵

FPNV定位矩阵对于评估心房颤动手术市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对心房颤动手术市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.房颤手术市场规模及预测如何？

2.在心房颤动手术市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.心房颤动手术市场的技术趋势和法规结构是什么？

4.心房颤动手术市场主要厂商的市场占有率是多少？

5.进入心房颤动手术市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 老年人心房颤动盛行率上升
      • 心律不整治疗中优先考虑心导管电气烧灼术
      • 增加 AF 项目以提高公众意识
    • 抑制因素
      • 与设备相关的监管问题
    • 机会
      • 对微创手术、较小的心臟切口和更短的术后恢復时间的需求日益增长。
      • 心房颤动心导管电气烧灼术技术进展
    • 任务
      • 缺乏熟练的专业人员和公众缺乏手术意识
  • 市场区隔分析
    • 产品：随着基于导管的手术的使用越来越多，对微创手术的需求也在增加。
    • 适应症：迷路手术作为心房颤动的首选治疗方法的出现
    • 最终用户：加速心臟病学和多专科中心进行的心房颤动手术
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章心房颤动手术市场：副产品

  • 心臟冷冻消融导管
  • 心臟定位系统

第七章 心房颤动手术市场（按适应症）

  • 心房颤动 (AFib)
  • 心房扑动
  • 心室上性心搏过速 (SVT)

第八章心房颤动手术市场：依最终用户分类

  • 心臟病学
  • 多专业

第九章北美和南美心房颤动手术市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区心房颤动手术市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲的心房颤动手术市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • GE 医疗保健推出用于治疗心房颤动的 CardioVisio。它是一种以患者为中心的数位化临床决策支援工具，可实现精准护理。
    • Biosense Webster 获得 FDA核准多种心房颤动消融产品，这些产品可用于无需透视的工作流程
    • Medtronic)用于房性心律不整治疗的 Aphera 标测和消融系统获得 CE 标誌核准
  • 战略分析和建议

第13章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-436901065DB6

[182 Pages Report] The Atrial Fibrillation Surgery Market size was estimated at USD 2.67 billion in 2023 and expected to reach USD 2.90 billion in 2024, at a CAGR 9.00% to reach USD 4.88 billion by 2030.

Atrial fibrillation surgery is a medical procedure to treat atrial fibrillation (AFib), an irregular and often rapid heart rate that can lead to poor blood flow, stroke, and other cardiovascular complications. Major types of atrial fibrillation surgeries include catheter ablation, surgical ablation, and left atrial appendage closure (LAAC). Over the years, there has been a significant prevalence of chronic diseases such as diabetes and hypertension, which are key risk factors for developing AFib; as a result, demand for effective AFib treatment options has surged. Innovations in minimally invasive techniques, such as catheter ablation, have significantly improved patient outcomes while reducing recovery time. However, product recalls associated with AFib surgical products, limited reimbursements for surgeries, and limited availability of surgeons to conduct the procedure also impact the market. Market players are creating affordable devices or techniques that enable greater accessibility to life-saving treatments for patients across different socioeconomic backgrounds. Continued research in areas such as artificial intelligence, robotics, and bioelectronic medicine is expected to lead to the development of innovative AFib surgery solutions that further improve patient outcomes and minimize complications.

KEY MARKET STATISTICS
Base Year [2023] USD 2.67 billion
Estimated Year [2024] USD 2.90 billion
Forecast Year [2030] USD 4.88 billion
CAGR (%) 9.00%

Product: Minimally invasive procedures are on demand with the rising utilization of catheter-based procedures

Catheter ablation products are minimally invasive procedures used to treat atrial fibrillation (AF) by isolating the pulmonary veins and creating lesions in the heart tissue to disrupt the abnormal electrical signals. These products offer a less invasive option for patients who are not suitable candidates for open-heart surgery or those who prefer a shorter recovery time. Surgical ablation products encompass various techniques such as maze procedure (cut-and-sew technique), radiofrequency (RF) ablation, and cryoablation performed during open-heart surgery or using minimally invasive approaches, including thoracoscopic surgery. These products address more complex cardiac arrhythmias that cannot be effectively treated alone with catheter-based techniques. While catheter-based procedures are favored due to their minimally invasive nature and quicker recovery times, surgical options offer a more comprehensive treatment for complex arrhythmias that cannot be adequately addressed using catheter techniques alone.

Indication: Emergence of maze procedure as a preferred treatment for atrial fibrillation

Arrhythmias are irregular heart rhythms induced by abnormal electrical activity in the heart. Atrial fibrillation is the most common type of arrhythmia affecting millions of people worldwide. The maze procedure, pulmonary vein isolation (PVI), and left atrial appendage closure (LAAC) are common surgical options for AFib treatment. Atrial flutter is a less common arrhythmia characterized by rapid and regular electrical signals originating from the atria. Catheter ablation is the preferred treatment option; however, atrial fibrillation surgery may be necessary in cases where ablation is unsuccessful or not suitable due to patient factors. Supraventricular tachycardia refers to rapid heart rhythms originating above the ventricles. Catheter ablation is the primary treatment for SVT, and atrial fibrillation surgery may be considered in cases with multiple arrhythmogenic foci or when ablation fails.

End-User: Accelerating cases of atrial fibrillation surgeries conducted in cardiology and multi-specialty centers

In the atrial fibrillation surgery landscape, cardiology and multi-specialty practices have distinct requirements and preferences regarding surgical interventions for atrial fibrillation. Cardiology-focused practices prioritize specialized devices explicitly designed for atrial fibrillation treatment, while multi-specialty settings seek versatility across disciplines and patient populations. Cardiologists specialized in diagnosing and treating heart diseases, including atrial fibrillation, necessitating advanced devices and procedures and new irrigated radiofrequency ablation catheters. Minimally invasive methods such as catheter ablation are the preferred choice for cardiologists due to their high success rates, reduced patient discomfort, and shorter recovery times. Multi-specialty practices provide an integrated approach to patient care by encompassing various medical disciplines under one roof. In these settings, diagnostic equipment and tools comprise ECG machines, echocardiography systems, and cardiac monitoring devices for accurate diagnosis and management of atrial fibrillation.

Regional Insights

North America's atrial fibrillation surgery market observes an advancing landscape driven by the well-established healthcare infrastructure and favorable reimbursement policies to conduct surgical procedures. There have been several innovative medication products and devices approved by the U.S. Food & Drug Administration (FDA) and Health Canada in the region, portraying an improved development scenario. In Asia-Pacific, countries such as India, Japan, and China have seen a rapid increase in AFib surgeries due to a large patient pool suffering from cardiovascular diseases uptaking surgical procedures. Substantial growth in medical tourism in Asia has accelerated the number of surgeries conducted in the region, expanding the need for advanced surgical tools and devices. The production aspect of AF surgery is growing in Asia, especially in China and Japan, due to the presence of major medical device manufacturers focusing on developing cost-effective solutions to cater to the ever-growing demand for affordable healthcare services. Europe is another significant market for AFib, with many European-based companies focusing on developing innovative cardiac devices used during AF surgeries. Key players have made substantial investments in research and development activities aimed at advancing surgical technologies for treating atrial fibrillation patients effectively.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Atrial Fibrillation Surgery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Atrial Fibrillation Surgery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Atrial Fibrillation Surgery Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Acesion Pharma ApS, Acutus Medical, Inc, Affera, Inc., AFreeze GmbH, Atrian Medical Ltd., AtriCure, Inc., AuriGen Medical, BIOTRONIK SE & CO. KG, Boston Scientific Corporation, Cardiofocus, Inc., CathRx Ltd, Cook Group Incorporated, F. Hoffmann-La Roche AG, GE HealthCare Technologies Inc., Healium Medical, Japan Lifeline Co., Johnson & Johnson Services, Inc., Kardium Inc., Koninklijke Philips N.V., Medtronic PLC, OMEICOS Therapeutics GmbH, Osypka AG, SentiAR, Inc, Siemens Healthcare GmbH, Stryker Corporation, Terumo Corporation, Thryv Therapeutics Inc., Toray Medical Co., Ltd., Vanguard AG, and Volta Medical.

Market Segmentation & Coverage

This research report categorizes the Atrial Fibrillation Surgery Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Cardiac Cryoablation Catheters
    • Cardiac Mapping System
  • Indication
    • Atrial Fibrillation (AFib)
    • Atrial Flutter
    • Supraventricular Tachycardia (SVT)
  • End-User
    • Cardiology
    • Multi Specialities
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Atrial Fibrillation Surgery Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Atrial Fibrillation Surgery Market?

3. What are the technology trends and regulatory frameworks in the Atrial Fibrillation Surgery Market?

4. What is the market share of the leading vendors in the Atrial Fibrillation Surgery Market?

5. Which modes and strategic moves are suitable for entering the Atrial Fibrillation Surgery Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in prevalence of atrial fibrillation in geriatric population
      • 5.1.1.2. Development in preference of catheter ablation for cardiac arrhythmia treatment
      • 5.1.1.3. Growing number of AF programs to enhance public awareness
    • 5.1.2. Restraints
      • 5.1.2.1. Regulatory issues associated with the devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing need for minimally invasive procedures, smaller cardiac incisions, and faster post-surgical recovery times
      • 5.1.3.2. Technological advances for catheter ablation of atrial fibrillation
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled professionals and awareness among the people about the surgery
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Minimally invasive procedures are on demand with the rising utilization of catheter-based procedures
    • 5.2.2. Indication: Emergence of maze procedure as a preferred treatment for atrial fibrillation
    • 5.2.3. End-User: Accelerating cases of atrial fibrillation surgeries conducted in cardiology and multi-specialty centers
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Atrial Fibrillation Surgery Market, by Product

  • 6.1. Introduction
  • 6.2. Cardiac Cryoablation Catheters
  • 6.3. Cardiac Mapping System

7. Atrial Fibrillation Surgery Market, by Indication

  • 7.1. Introduction
  • 7.2. Atrial Fibrillation (AFib)
  • 7.3. Atrial Flutter
  • 7.4. Supraventricular Tachycardia (SVT)

8. Atrial Fibrillation Surgery Market, by End-User

  • 8.1. Introduction
  • 8.2. Cardiology
  • 8.3. Multi Specialities

9. Americas Atrial Fibrillation Surgery Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Atrial Fibrillation Surgery Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Atrial Fibrillation Surgery Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. GE HealthCare Launches CardioVisio for Atrial Fibrillation, a Digital, Patient-Centric Clinical Decision Support Tool to Enable Precision Care
    • 12.3.2. Biosense Webster Receives FDA Approval for Multiple Atrial Fibrillation Ablation Products to be Used in a Workflow Without Fluoroscopy
    • 12.3.3. Medtronic Receives CE Mark Approval For Affera Mapping And Ablation System To Treat Atrial Arrhythmias
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. ATRIAL FIBRILLATION SURGERY MARKET RESEARCH PROCESS
  • FIGURE 2. ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ATRIAL FIBRILLATION SURGERY MARKET DYNAMICS
  • FIGURE 7. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. ATRIAL FIBRILLATION SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. ATRIAL FIBRILLATION SURGERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ATRIAL FIBRILLATION SURGERY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC CRYOABLATION CATHETERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC CRYOABLATION CATHETERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC MAPPING SYSTEM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIAC MAPPING SYSTEM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FIBRILLATION (AFIB), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FIBRILLATION (AFIB), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FLUTTER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY ATRIAL FLUTTER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SUPRAVENTRICULAR TACHYCARDIA (SVT), BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY SUPRAVENTRICULAR TACHYCARDIA (SVT), BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY MULTI SPECIALITIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY MULTI SPECIALITIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 31. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 32. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 33. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 34. AMERICAS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 36. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 38. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 39. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 40. ARGENTINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 41. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 42. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 43. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 44. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 45. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 46. BRAZIL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 47. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 48. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 49. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 50. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 51. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 52. CANADA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 53. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 54. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 55. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 56. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 57. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 58. MEXICO ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 59. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 60. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 61. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 62. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 63. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 66. UNITED STATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 76. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 78. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 79. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 80. AUSTRALIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 81. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 82. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 83. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 84. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 85. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 86. CHINA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 87. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 90. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 91. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. INDIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 94. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 95. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 96. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 97. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. INDONESIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 100. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 101. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 102. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 103. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 104. JAPAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 105. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 106. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 107. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 108. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 109. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. MALAYSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 112. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 113. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 114. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 115. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. PHILIPPINES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 118. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 119. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 120. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 121. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. SINGAPORE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 124. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 125. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 126. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 127. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 128. SOUTH KOREA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 129. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 130. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 131. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 132. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 133. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. TAIWAN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 136. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 137. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 138. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 139. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. THAILAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 142. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 143. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 144. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 145. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. VIETNAM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 155. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 156. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 157. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 158. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 159. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. DENMARK ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 164. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 165. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. EGYPT ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 168. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 169. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 170. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 171. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. FINLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 174. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 175. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 176. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 177. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 178. FRANCE ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 179. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 180. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 181. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 182. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 183. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. GERMANY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 186. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 187. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 188. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 189. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. ISRAEL ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 192. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 193. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 194. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 195. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. ITALY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 198. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 199. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 200. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 202. NETHERLANDS ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 203. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 204. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 205. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 206. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 207. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 208. NIGERIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 209. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 210. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 211. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 212. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 213. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 214. NORWAY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 215. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 216. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 217. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 218. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 219. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. POLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 224. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 225. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. QATAR ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 228. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 229. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 230. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 231. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 232. RUSSIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 233. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 234. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 236. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 238. SAUDI ARABIA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 239. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 240. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 241. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 242. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH AFRICA ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 245. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 246. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 247. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 248. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. SPAIN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 252. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 253. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 254. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 255. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. SWEDEN ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 258. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 259. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 260. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 262. SWITZERLAND ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 263. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 264. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 265. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 266. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 267. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. TURKEY ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 270. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 271. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 272. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 275. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 276. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED KINGDOM ATRIAL FIBRILLATION SURGERY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 281. ATRIAL FIBRILLATION SURGERY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 282. ATRIAL FIBRILLATION SURGERY MARKET, FPNV POSITIONING MATRIX, 2023